159837 生物科技
午间休市 08-20 11:30:00
资讯
新帖
简况
ETF异动解读|创新药全线爆发，疫苗ETF领涨近10%，港股创新药ETF、恒生创新药ETF、生物科技ETF集体飙升
格隆汇 · 17分钟前
ETF异动解读|创新药全线爆发，疫苗ETF领涨近10%，港股创新药ETF、恒生创新药ETF、生物科技ETF集体飙升
A股三大指数悉数高开 深成指涨1.03% 生物科技、贵金属板块涨幅居前
金吾财讯 · 09:27
A股三大指数悉数高开 深成指涨1.03% 生物科技、贵金属板块涨幅居前
A股三大指数悉数低开 沪指跌0.08% 互联网、生物科技等板块跌幅居前
金吾财讯 · 08-18 09:30
A股三大指数悉数低开 沪指跌0.08% 互联网、生物科技等板块跌幅居前
全球资产配置进入“去拥挤化”时刻！美银从AI算力转向价值、生物科技与大宗商品
智通财经 · 08-17
全球资产配置进入“去拥挤化”时刻！美银从AI算力转向价值、生物科技与大宗商品
爱普股份（603020）披露收购挪亚圣诺（太仓）生物科技有限公司100%股权进展公告，8月13日股价下跌1.98%
证券之星 · 08-13
爱普股份（603020）披露收购挪亚圣诺（太仓）生物科技有限公司100%股权进展公告，8月13日股价下跌1.98%
汇添富恒生生物科技ETF发起式联接(QDII)A基金经理变动：乐无穹不再担任该基金基金经理
证券之星 · 08-12
汇添富恒生生物科技ETF发起式联接(QDII)A基金经理变动：乐无穹不再担任该基金基金经理
【ETF动向】8月11日生物科技ETF易方达基金涨0.57%，份额减少5500万份
证券之星 · 08-12
【ETF动向】8月11日生物科技ETF易方达基金涨0.57%，份额减少5500万份
贝泰妮：公司系伊正（苏州）生物科技有限公司重要战略投资者
证券之星 · 08-05
贝泰妮：公司系伊正（苏州）生物科技有限公司重要战略投资者
生物科技公司Capricor Therapeutics面临FDA质疑与证券欺诈调查 股价连续暴跌
环球市场播报 · 07-28
生物科技公司Capricor Therapeutics面临FDA质疑与证券欺诈调查 股价连续暴跌
生物科技公司Apnimed冲刺美股：最高募资1.6亿美元
雷递网 · 07-28
生物科技公司Apnimed冲刺美股：最高募资1.6亿美元
最大赢家不是AI！生物科技成美股IPO“黑马” 平均回报率达55% 大幅跑赢整体市场
智通财经 · 07-21
最大赢家不是AI！生物科技成美股IPO“黑马” 平均回报率达55% 大幅跑赢整体市场
华芢生物-B(02396)中文名称变更为“青城新药生物科技(青岛)股份有限公司”
智通财经 · 07-17
华芢生物-B(02396)中文名称变更为“青城新药生物科技(青岛)股份有限公司”
港股异动 | 亮晴控股(03774))涨超14% 公司战略重心锚定“AI+高端生物科技护肤”
智通财经 · 07-14
港股异动 | 亮晴控股(03774))涨超14% 公司战略重心锚定“AI+高端生物科技护肤”
【ETF动向】6月29日生物科技ETF易方达基金涨7.16%，份额减少8100万份
证券之星 · 06-30
【ETF动向】6月29日生物科技ETF易方达基金涨7.16%，份额减少8100万份
传染病生物科技公司Alopexx(ALPX.US)上调IPO规模近两倍 拟募资3300万美元
智通财经 · 06-29
传染病生物科技公司Alopexx(ALPX.US)上调IPO规模近两倍 拟募资3300万美元
【新股IPO】岸迈生物科技向港交所主板提交上市申请
金吾财讯 · 06-24
【新股IPO】岸迈生物科技向港交所主板提交上市申请
港股IPO：岸迈生物科技有限公司-B递表港交所
每日经济新闻 · 06-24
港股IPO：岸迈生物科技有限公司-B递表港交所
爱普股份（603020）披露收购挪亚圣诺（太仓）生物科技有限公司100%股权进展公告，6月24日股价上涨1.59%
证券之星 · 06-24
爱普股份（603020）披露收购挪亚圣诺（太仓）生物科技有限公司100%股权进展公告，6月24日股价上涨1.59%
【新股IPO】广州知易生物科技股份有限公司向港交所主板递交上市申请
金吾财讯 · 06-18
【新股IPO】广州知易生物科技股份有限公司向港交所主板递交上市申请
Parabilis完成6.7亿美元IPO，创风投支持生物科技公司募资纪录
环球市场播报 · 06-11
Parabilis完成6.7亿美元IPO，创风投支持生物科技公司募资纪录
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"159837","market":"SZ","secType":"STK","nameCN":"生物科技","latestPrice":0.548,"timestamp":1787198736000,"preClose":0.515,"halted":0,"volume":115282209,"delay":0,"changeRate":0.0641,"floatShares":0,"shares":0,"eps":0,"marketStatus":"午间休市","change":0.033,"latestTime":"08-20 11:30:00","open":0.535,"high":0.549,"low":0.531,"amount":62515000,"amplitude":0.035,"askPrice":0.548,"askSize":42,"bidPrice":0.547,"bidSize":78,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787202000000},"marketStatusCode":3,"adr":0,"adjPreClose":0.515,"symbolType":"fund","openAndCloseTimeList":[[1787189400000,1787196600000],[1787202000000,1787209200000]],"highLimit":0.567,"lowLimit":0.464,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":0.049199,"marketValue":0,"turnoverRate":0,"status":0,"floatMarketCap":0},"requestUrl":"/m/hq/s/159837","defaultTab":"news","newsList":[{"id":"2660147002","title":"ETF异动解读|创新药全线爆发，疫苗ETF领涨近10%，港股创新药ETF、恒生创新药ETF、生物科技ETF集体飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=2660147002","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660147002?lang=zh_cn&edition=full","pubTime":"2026-08-20 11:49","pubTimestamp":1787197783,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["KCAI","BK1574","IBBJ","159643","BK1161","MEDX","XBI","IBBQ","AGNG","GDOC","159316","VXUS","BK4585","SYNB","BK4550","BK4588","FDN","LNGR","BK4581","159992","159837","IEIH","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660947234","title":"A股三大指数悉数高开 深成指涨1.03% 生物科技、贵金属板块涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2660947234","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660947234?lang=zh_cn&edition=full","pubTime":"2026-08-20 09:27","pubTimestamp":1787189245,"startTime":"0","endTime":"0","summary":"金吾财讯 | A股三大指数悉数高开，沪指涨0.33%，深成指涨1.03%，创业板指涨1.27%。盘面上看，生物科技、贵金属、通信设备等板块涨幅居前；煤炭、农业、银行等板块跌幅居前。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/MTYwMGM1ZDEwYjRjZDY4ZmI3MTk0ZDEyM2Y1MWFkMjMxODA4Mzk0Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MTYwMGM1ZDEwYjRjZDY4ZmI3MTk0ZDEyM2Y1MWFkMjMxODA4Mzk0Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988757","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03130","IEIH","BK4588","07233","GLDI","MEDX","82846","399001","03188","BK4581","GLDW","LNGR","83130","GDOC","BK4585","IBBJ","159837","02827","BK1147","02846","HBImain","XBI","AGNG","83188","159982","399300","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660545510","title":"A股三大指数悉数低开 沪指跌0.08% 互联网、生物科技等板块跌幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2660545510","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660545510?lang=zh_cn&edition=full","pubTime":"2026-08-18 09:30","pubTimestamp":1787016620,"startTime":"0","endTime":"0","summary":"金吾财讯 | A股三大指数悉数低开，沪指跌0.08%，深成指跌0.08%，创业板指跌0.25%。盘面上看，互联网、生物科技、文化传媒等板块跌幅居前；能源设备、石油天然气、教育等板块涨幅居前。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210625/YjI3NDA0ZDhiMGQ3ZDhlYjY1NzQ2OTEyNjkyMTk4MTc4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YjI3NDA0ZDhiMGQ3ZDhlYjY1NzQ2OTEyNjkyMTk4MTc4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988502","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1807302812.USD","BK0188","03147","159837","LU0067412154.USD","LU0501845795.SGD","LU1580142542.USD","BK0187","BK0012","LU1781817850.SGD","07234","000001","LU0072913022.USD","BK0278","LU1655091616.SGD","BK0183","BK0201","IE00B0JY6N72.USD","399006","LU1993786604.SGD","LU1226287529.USD","BK0028","LU0880133367.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660105476","title":"全球资产配置进入“去拥挤化”时刻！美银从AI算力转向价值、生物科技与大宗商品","url":"https://stock-news.laohu8.com/highlight/detail?id=2660105476","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660105476?lang=zh_cn&edition=full","pubTime":"2026-08-17 09:15","pubTimestamp":1786929314,"startTime":"0","endTime":"0","summary":"不过，该行警告称，从长期来看，最大规模的增量收益可能最终流向消费者和全球整体经济，而不是那些为大规模建设AI算力基础设施提供支持的科技企业。因此，美国银行转而看好大宗商品和其他实物资产。","market":"us","thumbnail":"https://static.tigerbbs.com/55eb327f580527889cf30bafa92692ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/55eb327f580527889cf30bafa92692ae"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480529.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["UPRO","HIBL","ITDF","LNGR","QQQX","DXD","SMAX","TRIO","WISE","IVV","09834","QALT","NMBL","EUCG","07522","QPX","DIA","SQQQ","SPXU","AGOX",".IXIC","GDMA",".DJI","161715","DMAX","SPYM","07266","SPYQ","SPUU","QLD","BK4588","IEIH","NDX","DDM","NOCT","BK4581","SH","TBFG","XBI","KNOW","GAL","MEDX","WLTG","DRAI","FPAA","07261","NAPR","SPYU","159837","SYNB","07568","BK4585","MVFG","WDAI","03455","TCTL","DDX","ITDI","ITDJ","NTSI","GPIQ","SPXS","AGNG","RNMN","ARP","UDOW","NJUL","SPDN","SSO","QQQM","QQQ","TQQQ","MMAX","PSQ","QDEC","KOOL",".SPX","YSPY","IBBJ","DOG","AVMA","03034","SDS","SPXL","02834","GDOC","TQQY","VOO","LEXI","GMOM","SDOW","09086","QMAR","GAA","EEV","03086","NDAA","BTR","NJAN","SPY","PCPP","QID","SPYH"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2659416879","title":"爱普股份（603020）披露收购挪亚圣诺（太仓）生物科技有限公司100%股权进展公告，8月13日股价下跌1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659416879","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659416879?lang=zh_cn&edition=full","pubTime":"2026-08-13 22:22","pubTimestamp":1786630939,"startTime":"0","endTime":"0","summary":"截至2026年8月13日收盘，爱普股份报收于10.4元，较前一交易日下跌1.98%，最新总市值为39.07亿元。近日，爱普香料集团股份有限公司发布《关于收购挪亚圣诺（太仓）生物科技有限公司100%股权的进展公告》。公告显示，公司通过全资子公司上海爱普鼎纯生命科技有限公司，以现金方式合计人民币45,000.00万元收购挪亚圣诺（太仓）生物科技有限公司100%股权。目标公司已变更为爱普生命科技持股80%，挪亚圣诺欧洲持股20%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300039701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159837","BK0226","HBImain","603020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658475919","title":"汇添富恒生生物科技ETF发起式联接(QDII)A基金经理变动：乐无穹不再担任该基金基金经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2658475919","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658475919?lang=zh_cn&edition=full","pubTime":"2026-08-12 09:32","pubTimestamp":1786498374,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年8月12日，汇添富恒生生物科技ETF发起式联接(QDII)（020634）发布公告，乐无穹不再担任该基金基金经理，离任日期为2026年8月12日，变更后汇添富恒生生物科技ETF发起式联接(QDII)（020634）的基金经理为董瑾。截止2026年8月11日，汇添富恒生生物科技ETF发起式联接(QDII)净值为1.6562，较上一日上涨0.5%，近一年下跌8.95%。本文数据来源于汇添富基金管理股份有限公司公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200009109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159837","164705","HBImain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658835944","title":"【ETF动向】8月11日生物科技ETF易方达基金涨0.57%，份额减少5500万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2658835944","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658835944?lang=zh_cn&edition=full","pubTime":"2026-08-12 08:04","pubTimestamp":1786493044,"startTime":"0","endTime":"0","summary":"证券之星消息，8月11日，生物科技ETF易方达基金（159837）涨0.57%，成交额6260.88万元。当日份额减少了5500万份，最新份额为28.26亿份，近20个交易日份额减少2.7亿份。当日资金净流出2087.38万元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为14.87亿元。生物科技ETF易方达基金跟踪标的为中证生物科技主题指数，成立（2021-01-14）以来超额回报为3.38%，近一个月超额回报为0.66%，管理人为易方达基金公司，基金经理为张湛 陈英嘉。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200006206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159837","HBImain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657594134","title":"贝泰妮：公司系伊正（苏州）生物科技有限公司重要战略投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2657594134","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657594134?lang=zh_cn&edition=full","pubTime":"2026-08-05 11:37","pubTimestamp":1785901043,"startTime":"0","endTime":"0","summary":"证券之星消息，贝泰妮(300957)08月05日在投资者关系平台上答复投资者关心的问题。投资者提问：公开信息显示，贵公司持有伊正（苏州）生物科技有限公司部分股权。伊正的全资子公司成都伊臻研发的“注射用聚左旋乳酸填充剂”已取得三类医疗器械注册证，产品获批用于颞部骨膜上层注射，改善成人轻中度颞部凹陷。伊正童颜针属于稀缺资源，贵公司是否考虑直接并购。贝泰妮回复：尊敬的投资者，您好。公司系伊正（苏州）生物科技有限公司重要战略投资者，具体信息及未来计划请以公司公告为准。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500017971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300957","HBImain","159837"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654885615","title":"生物科技公司Capricor Therapeutics面临FDA质疑与证券欺诈调查 股价连续暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2654885615","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654885615?lang=zh_cn&edition=full","pubTime":"2026-07-28 23:15","pubTimestamp":1785251700,"startTime":"0","endTime":"0","summary":"生物科技公司Capricor Therapeutics正面临严峻挑战，其股价近期大幅下挫——周一该股收盘重挫64.49%，周二早盘再跌逾15%。FDA审查人员对Capricor的核心候选药物deramiocel的疗效数据提出质疑，认为其关键性III期HOPE-3试验未能达到预设的主要和关键次要疗效终点。此外，多家律师事务所已对Capricor提起或正在调查证券欺诈集体诉讼。诉讼主要指控公司在2024年10月9日至2025年7月10日期间，就其获得FDA批准的可能性作出了虚假和误导性陈述，同时隐瞒了关于deramiocel安全性和有效性的不利事实。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-28/doc-inikksxz1845469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["161027","LNGR","BK4585","BK4007","BK4581","IBBJ","IEIH","LABU","HBImain","AGNG","BK4139","159837","BK4588","SYNB","GDOC","XBI","LENZ","BK4539","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654273030","title":"生物科技公司Apnimed冲刺美股：最高募资1.6亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2654273030","media":"雷递网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654273030?lang=zh_cn&edition=full","pubTime":"2026-07-28 10:37","pubTimestamp":1785206250,"startTime":"0","endTime":"0","summary":"美国生物科技公司Apnimed（股票代码：“APMD”）日前递交招股书，准备在美国纳斯达克上市。","market":"sh","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260728/6392083182331291075080922.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260728/6392083182331291075080922.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n34488/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["SYNB","IEIH","159837","BK4588","IBBJ","BK4581","XBI","APMD","BK4585","LNGR","MEDX","GDOC","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653096952","title":"最大赢家不是AI！生物科技成美股IPO“黑马” 平均回报率达55% 大幅跑赢整体市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2653096952","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653096952?lang=zh_cn&edition=full","pubTime":"2026-07-21 23:23","pubTimestamp":1784647380,"startTime":"0","endTime":"0","summary":"数据显示，2026年以来，美国生物科技和制药企业IPO的加权平均回报率达到55%，而剔除特殊目的收购公司及其他金融工具后，美国IPO市场整体加权平均回报率则为亏损4.4%。数据显示，截至目前，2026年美国生物科技IPO数量已超过2025年全年仅8家的水平。融资规模方面，今年美国生物科技IPO募资总额已突破50亿美元，约为去年的三倍。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470619.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SYNB","BK4127","REDS","159837","AGIX","LNGR","AIPO","BK4588","QTOC","XBI","KCE","VTHR","IEIH","FRHC","IPOS","HBImain","CHAT","GDOC","AGNG","ARTY","BK4581","IBBJ","BK4585","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652406337","title":"华芢生物-B(02396)中文名称变更为“青城新药生物科技(青岛)股份有限公司”","url":"https://stock-news.laohu8.com/highlight/detail?id=2652406337","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652406337?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:42","pubTimestamp":1784277760,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华芢生物-B(02396)发布公告，公司中文名称已由“华芢生物科技(青岛)股份有限公司”更改为“青城新药生物科技(青岛)股份有限公司”。公司英文名称保持不变。自2026年7月22日上午九时正起，在联交所买卖股份的中文股份简称将由“华芢生物-B”更改为“青城新药-B”。买卖所用英文股份简称保持不变，仍为“B&K CORP-B”，公司股份代号亦保持不变，仍为“2396”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1468977.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","MEDX","SYNB","159837","HBImain","GDOC","XBI","02396","AGNG","BK4581","BK1161","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651073122","title":"港股异动 | 亮晴控股(03774))涨超14% 公司战略重心锚定“AI+高端生物科技护肤”","url":"https://stock-news.laohu8.com/highlight/detail?id=2651073122","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651073122?lang=zh_cn&edition=full","pubTime":"2026-07-14 14:32","pubTimestamp":1784010753,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，亮晴控股)涨超14%，截至发稿，涨12.95%，报18.4港元，成交额996.48万港元。消息面上，今年6月底，亮晴控股正式由港交所创业板转往主板上市，有望提升股份交易流动性，为公司长远发展提供更大的灵活性。据悉，亮晴控股是香港本土医学美容服务提供商，截至目前，公司共经营16家医学美容中心。面向未来，亮晴控股正将战略重心锚定“AI+高端生物科技护肤”这一新兴赛道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1467096.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VTHR","BK4585","CHAT","BK4581","AIPO","HBImain","AGNG","SYNB","159837","BK4588","GDOC","BK1215","03774","ARTY","KCAI","XBI","AGIX","VXUS","QTOC","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647588541","title":"【ETF动向】6月29日生物科技ETF易方达基金涨7.16%，份额减少8100万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2647588541","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647588541?lang=zh_cn&edition=full","pubTime":"2026-06-30 07:32","pubTimestamp":1782775939,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日，生物科技ETF易方达基金（159837）涨7.16%，成交额9059.12万元。当日份额减少了8100万份，最新份额为31.37亿份，近20个交易日份额增加1200万份。当日资金净流入6191.36万元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为14.53亿元。生物科技ETF易方达基金跟踪标的为中证生物科技主题指数，成立（2021-01-14）以来超额回报为2.71%，近一个月超额回报为0.37%，管理人为易方达基金公司，基金经理为张湛 陈英嘉。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000007323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159837","HBImain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647324338","title":"传染病生物科技公司Alopexx(ALPX.US)上调IPO规模近两倍 拟募资3300万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647324338","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647324338?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:16","pubTimestamp":1782721009,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于开发针对细菌、真菌及寄生虫感染免疫疗法、处于药物临床二期阶段的生物科技公司Alopexx于上周五上调了其即将进行的首次公开募股的拟定交易规模。Alopexx最初于2022年3月提交申请，并于2022年8月首次确定发行条款。据了解，Alopexx核心在研药物F598已完成一期临床试验与二期初步试验，试验显示药物耐受性良好，未出现严重不良反应。Alopexx成立于2006年，计划在纽约证券交易所美国交易所上市，股票代码为“ALPX”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460289.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","159837","BK4581","BK4585","XBI","BK4588","HBImain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645500814","title":"【新股IPO】岸迈生物科技向港交所主板提交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2645500814","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645500814?lang=zh_cn&edition=full","pubTime":"2026-06-24 23:27","pubTimestamp":1782314821,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据港交所6月24日文件披露，岸迈生物科技有限公司向港交所主板递交B类生物科技企业上市申请，联席保荐人为中信证券、招银国际。股权层面，吴辰冰及其家族组成Sanaron集团为单一最大股东，通过信托合计拥有上市后最大投票权；公司完成多轮融资，投资方包括FIIFOverseas、DechengUSDFund等。本次募资拟用于核心产品EMB-01临床试验、其余临床管线推进、扩充早期研发管线、补充日常营运资金。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/YTdjODg5ZDM1NDI1NjgyNDQyMw==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YTdjODg5ZDM1NDI1NjgyNDQyMw==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984434","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HBImain","IPOS","HEXmain","XBI","BK4581","159837","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645164538","title":"港股IPO：岸迈生物科技有限公司-B递表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2645164538","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645164538?lang=zh_cn&edition=full","pubTime":"2026-06-24 21:11","pubTimestamp":1782306660,"startTime":"0","endTime":"0","summary":"每经AI快讯，6月24日，利弗莫尔证券显示，岸迈生物科技有限公司-B向港交所提交上市申请书，联席保荐人为中信证券、招银国际。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-06-24/doc-iniepkru2955723.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-06-24/doc-iniepkru2955723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["VXUS","BK4588","HBImain","IPOS","159837","HEXmain","BK4581","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645899706","title":"爱普股份（603020）披露收购挪亚圣诺（太仓）生物科技有限公司100%股权进展公告，6月24日股价上涨1.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645899706","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645899706?lang=zh_cn&edition=full","pubTime":"2026-06-24 17:48","pubTimestamp":1782294523,"startTime":"0","endTime":"0","summary":"截至2026年6月24日收盘，爱普股份报收于14.7元，较前一交易日上涨1.59%，最新总市值为55.22亿元。该股当日开盘14.45元，最高14.86元，最低13.99元，成交额达2.21亿元，换手率为4.06%。爱普香料集团股份有限公司于近日披露《关于收购挪亚圣诺（太仓）生物科技有限公司100%股权的进展公告》。公告显示，公司通过全资子公司上海爱普鼎纯生命科技有限公司，以现金方式合计人民币45,000.00万元收购挪亚圣诺（太仓）生物科技有限公司100%股权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400033223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","HBImain","603020","159837"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644408414","title":"【新股IPO】广州知易生物科技股份有限公司向港交所主板递交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2644408414","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644408414?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:42","pubTimestamp":1781793770,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据港交所2026年6月18日文件，广州知易生物科技股份有限公司向港交所主板递交上市申请，联席保荐人为兴证国际、国投证券国际。股权架构上，创始人智博士通过持股平台珠海益畅达持有公司 37.26% 股份，为控股股东；多家产业及国资基金为外部主要投资方，上市后实控人仍维持控制权。本次募资将按比例分配：主要投入 SK08 各适应症国内外临床与注册、SK10 全球临床开发，剩余资金用于技术平台迭代、早期管线拓展及补充营运资金。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/YjE3MzU0MjU2ODIzMjIz.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YjE3MzU0MjU2ODIzMjIz.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984127","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159837","BK4585","BK4588","BK4581","HEXmain","IPOS","XBI","HBImain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642928261","title":"Parabilis完成6.7亿美元IPO，创风投支持生物科技公司募资纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=2642928261","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642928261?lang=zh_cn&edition=full","pubTime":"2026-06-11 20:49","pubTimestamp":1781182140,"startTime":"0","endTime":"0","summary":"临床阶段生物制药公司Parabilis Medicines本周完成了有史以来规模最大的风投支持生物科技首次公开募股，筹资约6.7亿美元，超出此前由Kailera Therapeutics在今年5月创下的6.25亿美元纪录。 Parabilis成立于2015年，前身为FogPharma，由哈佛大学教授Gregory Verdine创立。 Parabilis此前已通过私募融资筹集超过8亿美元，投资者包括ARCH Venture Partners、Fidelity Investments、RA Capital Management等知名机构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-11/doc-iniazyeh5454068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159837","BK4585","BK4588","BK4581","IPOS","XBI","HBImain"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787198796937,"stockEarnings":[{"period":"1week","weight":-0.0172},{"period":"1month","weight":0.0619},{"period":"3month","weight":0.1052},{"period":"6month","weight":0.0279},{"period":"1year","weight":-0.0568},{"period":"ytd","weight":0.0425}],"compareEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":0.0259},{"period":"3month","weight":-0.0448},{"period":"6month","weight":-0.046},{"period":"1year","weight":0.0448},{"period":"ytd","weight":-0.0188}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物科技(159837)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物科技(159837)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物科技,159837,生物科技股票,生物科技股票老虎,生物科技股票老虎国际,生物科技行情,生物科技股票行情,生物科技股价,生物科技股市,生物科技股票价格,生物科技股票交易,生物科技股票购买,生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物科技(159837)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物科技(159837)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}